Meanwhile, an obvious decrease in the uptake of HZ@GD was found in B16‐F10 cells pretreated with anti‐CD44 antibody than that in PIG1 cells, suggesting that CD44‐mediated actively targeting mechanism facilitates the uptake of HZ@GD for tumor cells. Here, CD44 is linked to neoplasm.